Literature DB >> 27207669

Liver carcinogenesis: from naughty chemicals to soothing fat and the surprising role of NRF2.

Michael Karin1, Debanjan Dhar2.   

Abstract

The liver is a key metabolic organ that is essential for production of blood proteins, lipid and sugar metabolism and detoxification of naturally occurring and foreign harmful chemicals. To maintain its mass and many essential functions, the liver possesses remarkable regenerative capacity, but the latter also renders it highly susceptible to carcinogenesis. In fact, liver cancer often develops in the context of chronic liver injury. Currently, primary liver cancer is the second leading cause of cancer-related deaths, and as the rates of other cancers have been declining, the incidence of liver cancer continues to rise with an alarming rate. Although much remains to be accomplished in regards to liver cancer therapy, we have learned a great deal about the molecular etiology of the most common form of primary liver cancer, hepatocellular carcinoma (HCC). Much of this knowledge has been obtained from studies of mouse models, using either toxic chemicals, a combination of fatty foods and endoplasmic reticulum stress or chronic activation of specific metabolic pathways. Surprisingly, NRF2, a transcription factor that was initially thought to protect the liver from oxidative stress, was found to play a key role in promoting HCC pathogenesis.
© The Author 2016. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27207669      PMCID: PMC4876993          DOI: 10.1093/carcin/bgw060

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  56 in total

1.  Sex differences: Luck of the chromosomes.

Authors:  Courtney Humphries
Journal:  Nature       Date:  2014-12-04       Impact factor: 49.962

Review 2.  From NAFLD to NASH to cirrhosis-new insights into disease mechanisms.

Authors:  Alexander Wree; Lori Broderick; Ali Canbay; Hal M Hoffman; Ariel E Feldstein
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-08-20       Impact factor: 46.802

3.  Hepatocyte IKKbeta/NF-kappaB inhibits tumor promotion and progression by preventing oxidative stress-driven STAT3 activation.

Authors:  Guobin He; Guann-Yi Yu; Vladislav Temkin; Hisanobu Ogata; Christian Kuntzen; Toshiharu Sakurai; Wolfgang Sieghart; Markus Peck-Radosavljevic; Hyam L Leffert; Michael Karin
Journal:  Cancer Cell       Date:  2010-03-16       Impact factor: 31.743

4.  Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults.

Authors:  Eugenia E Calle; Carmen Rodriguez; Kimberly Walker-Thurmond; Michael J Thun
Journal:  N Engl J Med       Date:  2003-04-24       Impact factor: 91.245

Review 5.  Immune surveillance of tumors.

Authors:  Jeremy B Swann; Mark J Smyth
Journal:  J Clin Invest       Date:  2007-05       Impact factor: 14.808

6.  Toxicant-associated steatohepatitis in vinyl chloride workers.

Authors:  Matt Cave; Keith Cameron Falkner; Mukunda Ray; Swati Joshi-Barve; Guy Brock; Rehan Khan; Marjorie Bon Homme; Craig J McClain
Journal:  Hepatology       Date:  2010-02       Impact factor: 17.425

Review 7.  p62/SQSTM1/A170: physiology and pathology.

Authors:  Masaaki Komatsu; Shun Kageyama; Yoshinobu Ichimura
Journal:  Pharmacol Res       Date:  2012-07-25       Impact factor: 7.658

8.  Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production.

Authors:  Willscott E Naugler; Toshiharu Sakurai; Sunhwa Kim; Shin Maeda; Kyounghyun Kim; Ahmed M Elsharkawy; Michael Karin
Journal:  Science       Date:  2007-07-06       Impact factor: 47.728

Review 9.  Toxicant-associated steatohepatitis.

Authors:  Banrida Wahlang; Juliane I Beier; Heather B Clair; Heather J Bellis-Jones; K Cameron Falkner; Craig J McClain; Matt C Cave
Journal:  Toxicol Pathol       Date:  2012-12-21       Impact factor: 1.902

10.  Antiviral therapy for prevention of hepatocellular carcinoma in chronic hepatitis C: systematic review and meta-analysis of randomised controlled trials.

Authors:  Nina Kimer; Emilie Kristine Dahl; Lise Lotte Gluud; Aleksander Krag
Journal:  BMJ Open       Date:  2012-10-22       Impact factor: 2.692

View more
  16 in total

1.  Dibenzoylmethane Protects Against CCl4-Induced Acute Liver Injury by Activating Nrf2 via JNK, AMPK, and Calcium Signaling.

Authors:  Mingnan Cao; Huixia Wang; Limei Guo; Simin Yang; Chun Liu; Tin Oo Khor; Siwang Yu; Ah-Ng Kong
Journal:  AAPS J       Date:  2017-08-21       Impact factor: 4.009

2.  Chaperone-Mediated Autophagy Promotes Beclin1 Degradation in Persistently Infected Hepatitis C Virus Cell Culture.

Authors:  Yucel Aydin; Christopher M Stephens; Srinivas Chava; Zahra Heidari; Rajesh Panigrahi; Donkita D Williams; Kylar Wiltz; Antoinette Bell; Wallace Wilson; Krzysztof Reiss; Srikanta Dash
Journal:  Am J Pathol       Date:  2018-08-01       Impact factor: 4.307

Review 3.  Integrated stress response in hepatitis C promotes Nrf2-related chaperone-mediated autophagy: A novel mechanism for host-microbe survival and HCC development in liver cirrhosis.

Authors:  Srikanta Dash; Yucel Aydin; Tong Wu
Journal:  Semin Cell Dev Biol       Date:  2019-08-08       Impact factor: 7.727

Review 4.  Activation of Nrf2 signaling by natural products-can it alleviate diabetes?

Authors:  Manuel Matzinger; Katrin Fischhuber; Elke H Heiss
Journal:  Biotechnol Adv       Date:  2017-12-28       Impact factor: 14.227

Review 5.  Genetic alterations in hepatocellular carcinoma: An update.

Authors:  Zhao-Shan Niu; Xiao-Jun Niu; Wen-Hong Wang
Journal:  World J Gastroenterol       Date:  2016-11-07       Impact factor: 5.742

6.  CD24-p53 axis suppresses diethylnitrosamine-induced hepatocellular carcinogenesis by sustaining intrahepatic macrophages.

Authors:  Dongling Li; Minling Hu; Ying Liu; Peiying Ye; Peishuang Du; Chi-Shan Li; Liang Cheng; Ping Liu; Jing Jiang; Lishan Su; Shengdian Wang; Pan Zheng; Yang Liu
Journal:  Cell Discov       Date:  2018-02-06       Impact factor: 10.849

7.  Activation of PERK-Nrf2 oncogenic signaling promotes Mdm2-mediated Rb degradation in persistently infected HCV culture.

Authors:  Yucel Aydin; Milad Chedid; Srinivas Chava; Donkita Danielle Williams; Shuanghu Liu; Curt H Hagedorn; Suchitra Sumitran-Holgersson; Krzysztof Reiss; Krzysztof Moroz; Hua Lu; Luis A Balart; Srikanta Dash
Journal:  Sci Rep       Date:  2017-08-23       Impact factor: 4.379

8.  Isothiocyanates induce UGT1A1 in humanized UGT1 mice in a CAR dependent fashion that is highly dependent upon oxidative stress.

Authors:  Emiko Yoda; Miles Paszek; Camille Konopnicki; Ryoichi Fujiwara; Shujuan Chen; Robert H Tukey
Journal:  Sci Rep       Date:  2017-04-19       Impact factor: 4.379

9.  Anti-cancer activities of allyl isothiocyanate and its conjugated silicon quantum dots.

Authors:  Peng Liu; Mehrnaz Behray; Qi Wang; Wei Wang; Zhigang Zhou; Yimin Chao; Yongping Bao
Journal:  Sci Rep       Date:  2018-01-18       Impact factor: 4.379

Review 10.  p53 as a Dichotomous Regulator of Liver Disease: The Dose Makes the Medicine.

Authors:  Jelena Krstic; Markus Galhuber; Tim J Schulz; Michael Schupp; Andreas Prokesch
Journal:  Int J Mol Sci       Date:  2018-03-20       Impact factor: 6.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.